ALUNNO, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 1.393
EU - Europa 741
AS - Asia 394
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
SA - Sud America 1
Totale 2.537
Nazione #
US - Stati Uniti d'America 1.388
IE - Irlanda 274
CN - Cina 176
TR - Turchia 123
SE - Svezia 99
DE - Germania 92
UA - Ucraina 85
SG - Singapore 81
IT - Italia 69
GB - Regno Unito 44
FI - Finlandia 26
FR - Francia 20
BE - Belgio 10
IN - India 7
NL - Olanda 7
AU - Australia 4
EU - Europa 4
VN - Vietnam 4
CA - Canada 3
CH - Svizzera 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
JP - Giappone 2
AT - Austria 1
CO - Colombia 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
HN - Honduras 1
IM - Isola di Man 1
LT - Lituania 1
LV - Lettonia 1
PR - Porto Rico 1
RO - Romania 1
RU - Federazione Russa 1
Totale 2.537
Città #
Jacksonville 326
Chandler 315
Dublin 266
Boardman 102
Izmir 78
Singapore 56
Nanjing 53
Wilmington 53
New York 51
Lawrence 48
Princeton 48
San Mateo 34
Beijing 30
Ashburn 28
Ann Arbor 27
L'aquila 22
Nanchang 20
Pescara 15
Seattle 15
Dearborn 14
Des Moines 14
Los Angeles 14
Milan 14
Woodbridge 11
Shanghai 10
Verona 10
Norwalk 9
Tianjin 9
Dallas 8
Jiaxing 8
Hebei 7
Mountain View 7
Munich 7
Brussels 6
Philadelphia 6
Pune 5
Zhengzhou 5
Berlin 4
Bremen 4
Changsha 4
Dong Ket 4
Hangzhou 4
Leuven 4
Ningbo 4
Shenyang 4
Amsterdam 3
Cedar Knolls 3
Falls Church 3
Forest City 3
Frankfurt am Main 3
Jinan 3
Kunming 3
Rome 3
Brno 2
Englewood 2
Fremont 2
Grafing 2
Helsinki 2
Jinhua 2
Redwood City 2
Santa Clara 2
Sydney 2
Arlington 1
Athens 1
Bournemouth 1
Brindisi 1
Brisbane 1
Central District 1
Columbus 1
Copenhagen 1
Douglas 1
Düsseldorf 1
Edinburgh 1
Hefei 1
Illawong 1
Kitzingen 1
Kocaeli 1
Lanzhou 1
Lappeenranta 1
L’Aquila 1
Madrid 1
Manchester 1
Mcallen 1
Odesa 1
Paris 1
Porto 1
Reston 1
Riga 1
Rio Comayagua 1
San Juan 1
Schull 1
Smithers 1
Suzhou 1
Taizhou 1
Tappahannock 1
Timisoara 1
Toronto 1
Vancouver 1
Vienna 1
Vilnius 1
Totale 1.863
Nome #
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: Results of a large multicentre study 86
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 76
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 75
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. 74
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 73
Unmasking the pathogenic role of il-17 axis in primary sj¨ogren’s syndrome: A new era for therapeutic targeting? 72
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 70
Common Features in Lymphoproliferative Complications in the Course of Primary Sjo‥gren’s Syndrome: Results From a Multicenter Cohort of 1170 Patients 68
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 66
Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis? 65
CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement. 65
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients with Sjögren's Syndrome: Comment on the Article by Nocturne et al 64
Serological biomarkers of b-cell lymphoproliferative disorders in patients with primary sjögren’s syndrome: retrospective study in a large italian cohort 63
Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis 63
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 62
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 58
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. 57
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 57
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome 57
Diet in rheumatoid arthritis versus systemic lupus erythematosus: Any differences? 56
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 54
The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humans. 51
PREVALENCE AND PREDICTIVE ROLE OF TRADITIONAL CARDIOVASCULAR RISK FACTORS IN A COHORT OF SJÖGREN'S SYNDROME PATIENTS 50
Rituximab in primary Sjögren's syndrome: a ten-year journey 50
Lymphoma and Lymphomagenesis in Primary Sjögren's Syndrome 50
Characteristics of primary sjögren’s syndrome (PSS) patients with cryoglobulinemia in a large cohort of patients, and differences between hypergammaglobulinemic and cryoglobulinemic vasculitis in PSS 49
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 49
EFFICACY AND SAFETY OF RITUXIMAB ORIGINATOR AND BIOSIMILAR IN PRIMARY SJOGREN'S SYNDROME IN A REAL-LIFE SETTING 48
IL-17 PRODUCING DOUBLE NEGATIVE (DN) T CELL PHENOTYPE AND FUNCTION IN PRIMARY SJÖGREN'S SYNDROME 47
Pericarditis after sars‐cov‐2 infection: Another pebble in the mosaic of long covid? 47
Histopathology of salivary glands 45
Adherence to the Mediterranean diet and the impact on clinical features in primary Sjögren's syndrome 45
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 44
The kaleidoscope of neurological manifestations in primary Sjögren's syndrome 42
CLINICAL AND IMAGING FEATURES OF ARTICULAR MANIFESTATIONS IN PRIMARY SJOGREN'S SYNDROME: SIMILARITIES AND DIFFERENCES ACCORDING TO THE TIME OF ONSET 42
12-MONTH OUTCOMES IN OVERWEIGHT/OBESE USERS WITH MENTAL DISORDERS FOLLOWING A MULTI-ELEMENT TREATMENT INCLUDING DIET, PHYSICAL ACTIVITY, AND POSITIVE THINKING: THE REAL-WORLD ‘AN APPLE A DAY’ CONTROLLED TRIAL 41
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 41
The impact of fibromyalgia in spondyloarthritis: From classification criteria to outcome measures 40
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis 40
Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units 39
THU0681 Baseline ESSDAI/DAS scores in 8061 patients with primary sjÖgren syndrome: characterization of systemic disease 38
The challenge to interpret conflicting results and the need of a univocal definition for germinal centres in primary Sjögren's syndrome 36
Thymic Stromal Lymphopoietin (TSLP) as a Biomarker of Primary Sjogren's Syndrome (pSS) and Related Lymphoma: Results in Independent Cohorts 36
OP0044 Antibodies anti-saccharomyces cerevisiae in primary sjÖgren's syndrome: prevalence, clinical associations and possible cross-reactivity with disease specific autoantigens 36
Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid Arthritis 34
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 27
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 27
SAT0641 Performance and agreement of different operators and histological techniques for the assessment of germinal centres in minor salivary glands in primary sjÖgren’s syndrome 26
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares 20
Neurological Involvement in a Cohort of Primary Sjogren's Syndrome Patients: Results of a Multicenter Italian Study 18
The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren’s Syndrome: Is Uric Acid the Missing Link? 17
Electrocardiographic Abnormalities in Hospitalized Patients with COVID-19 and the Associations with Clinical Outcome 11
The Impact of SARS-CoV-2 Outbreak on Primary Sjögren's Syndrome: An Italian Experience 10
Different clinical presentations of primary Sjögren's syndrome: Not only a matter of age. Comment on: “Elderly-onset primary Sjögren's syndrome focused on clinical and salivary gland ultrasonographic features by Lee et al. Joint Bone Spine. 2021;88:105132” 9
SpA plus IBD or IBD plus SpA: Does commutative property apply? 9
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 5
Totale 2.600
Categoria #
all - tutte 12.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.831


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020228 0 0 0 1 2 39 43 14 53 18 5 53
2020/2021347 2 42 0 44 47 14 46 0 54 14 69 15
2021/2022263 10 11 38 24 8 10 2 15 24 8 24 89
2022/2023810 69 44 17 89 86 96 0 46 318 8 29 8
2023/2024232 23 13 11 18 24 80 1 13 1 14 5 29
2024/2025171 38 20 99 14 0 0 0 0 0 0 0 0
Totale 2.600